<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <caption>PMC6129014</caption>
 <thead>
  <tr>
   <th>label</th>
   <th>caption</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>
    <a href="table_1.xml">Figure 1</a>
   </td>
   <td>DCEO inhibited the production of NO and PGE2 and the express ... </td>
  </tr>
  <tr>
   <td>
    <a href="table_2.xml">Figure 2</a>
   </td>
   <td>DCEO reduced the production of cytokines and chemokines in L ... </td>
  </tr>
  <tr>
   <td>
    <a href="table_3.xml">Figure 3</a>
   </td>
   <td>DCEO decreased mRNA levels of cytokines and chemokines in LP ... </td>
  </tr>
  <tr>
   <td>
    <a href="table_4.xml">Figure 4</a>
   </td>
   <td>DCEO affected the molecular components of the IRAK/NF-κB, IR ... </td>
  </tr>
  <tr>
   <td>
    <a href="table_5.xml">Figure 5</a>
   </td>
   <td>DCEO modulates the molecular components of the IRAK/NF-κB, I ... </td>
  </tr>
  <tr>
   <td>
    <a href="table_6.xml">Figure 6</a>
   </td>
   <td>DCEO inhibited nuclear localization of NF-κB, AP-1, and IRF3 ... </td>
  </tr>
  <tr>
   <td>
    <a href="table_7.xml">Figure 7</a>
   </td>
   <td>DCEO inhibited nuclear localization of NF-κB in LPS-stimulat ... </td>
  </tr>
  <tr>
   <td>
    <a href="table_8.xml">Figure 8</a>
   </td>
   <td>A schematic diagram showing the association of IRAK/NF-κB, I ... </td>
  </tr>
 </tbody>
</table>
